Clinical Trials Search at Vanderbilt-Ingram Cancer Center
A Study of Botensilimab and Balstilimab for the Treatment of Colorectal Cancer
Multiple Cancer Types
This is an open-label, Phase 2, multicenter study to evaluate the efficacy, safety,
tolerability, and pharmacokinetic profiles of botensilimab as monotherapy and in combination
with balstilimab or standard-of-care treatments in participants with refractory metastatic
colorectal cancer.
tolerability, and pharmacokinetic profiles of botensilimab as monotherapy and in combination
with balstilimab or standard-of-care treatments in participants with refractory metastatic
colorectal cancer.
Colon,
Rectal
II
Eng, Cathy
NCT05608044
VICCGI22106